Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma

Published:2020-02-03 Issue:2 Volume:38 Page:153-161
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Galli Eugenio¹^ORCID,Cuccaro Annarosa²,Maiolo Elena¹²,Bellesi Silvia²,D'Alò Francesco¹²,Fusco Domenico³,Colloca Giuseppe⁴³,De Stefano Valerio¹²,Hohaus Stefan¹²

Affiliation:

1. Istituto di Ematologia Università Cattolica del Sacro Cuore Rome Italy

2. Area di Ematologia Fondazione Policlinico Universitario A. Gemelli, IRCCS Rome Italy

3. Area Invecchiamento, Ortopedia e Riabilitazione Fondazione Policlinico Universitario A. Gemelli, IRCCS Rome Italy

4. Istituto di Geriatria Università Cattolica del Sacro Cuore Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2715

Reference30 articles.

1. HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

2. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis

3. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009

4. A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

5. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis;Landgren O;Haematologica,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients;Leukemia & Lymphoma;2024-09-13

2. Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review;Journal of Clinical Medicine;2023-09-22

3. A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma;Blood Advances;2023-07-13

4. Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity;Frontiers in Oncology;2023-01-13

5. Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades;Cancer Management and Research;2022-06